上皮-间质转化与microRNA:口腔癌的挑战与未来展望
本文综述了microRNA在上皮-间质转化(EMT)调控中的作用。研究基于PubMed检索2010年1月1日至2018年1月31日发表的英文文献,聚焦口腔鳞状细胞癌(OSCC)。结论提出靶向EMT型细胞、协调microRNA和/或疏水药物可能改善OSCC患者预后。
要点
- EMT是OSCC的重要标志,microRNA调控网络参与其病理生理过程。
- 靶向EMT型细胞并联合microRNA或疏水药物是潜在治疗策略。
- 需从生物学到临床应用设计新的研究和策略。
核心结论
- 靶向EMT型细胞、协调microRNA和/或疏水药物可能改善OSCC患者预后。
研究设计与样本
- 基于PubMed检索2010年1月1日至2018年1月31日发表的英文文献进行综述。
主要发现
- microRNA调控网络似乎是OSCC病理生理中EMT的标志,为从生物学到临床应用设计新研究和策略带来日益增长的挑战。
临床怎么用
- 可考虑将靶向EMT型细胞的策略与microRNA和/或疏水药物联合,作为改善OSCC预后的潜在方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck cancer is the sixth most common cancer worldwide, with oral squamous cell carcinoma (OSCC) being the most representative type. OSCC is a public health problem with high morbidity and poor survival rate. Epithelial-mesenchymal transition is emerging as a hallmark in OSCC. METHODS: In this study, we described the role of microRNAs in epithelial-mesenchymal transition regulation in OSCC based on a PubMed search using articles published in English between January 1, 2010, and January 31, 2018. RESULTS: MicroRNA's regulatory networks seem to be a hallmark of epithelial-mesenchymal transition in OSCC pathophysiology becoming a growing challenge to design new studies and strategies from biology to clinical applications. CONCLUSION: Therefore, we propose that targeting therapies to epithelial-mesenchymal transition-type cells, namely, coordinating microRNAs and/or hydrophobic drugs, such as conventional therapy, could be a promising strategy to improve the outcomes of patients with OSCC.
引用
- Domingues CSDC, Serambeque BP, Laranjo Cândido MS, et al. Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer. Head Neck. 2018. PMID: 30120853. doi:10.1002/hed.25381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。